MassCheck® Antiepileptic Drugs Plasma Controls

MassCheck® Antiepileptic Drugs Plasma Controls

   

Order no.: 0249/XT/RUO; 0250/XT/RUO; 0251/XT/RUO

MassTox® Series A

Product Name Qty
MassCheck® Antiepileptic Drugs Plasma Control, Bi-Level (I+II)
Order no.: 0249/XT/RUO
MassCheck® Antiepileptic Drugs Plasma Control, Level I
Order no.: 0250/XT/RUO
MassCheck® Antiepileptic Drugs Plasma Control, Level II
Order no.: 0251/XT/RUO

Description

MassCheck® Antiepileptic Drugs Plasma Controls, lyophilised
For MassTox® Series A Parameter Set Antiepileptic Drugs in Serum/Plasma.

0249/XT/RUO MassCheck® Antiepileptic Drugs Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 1 ml
0250/XT/RUO MassCheck® Antiepileptic Drugs Plasma Control, Level I (lyoph.), 5 x 1 ml
0251/XT/RUO MassCheck® Antiepileptic Drugs Plasma Control, Level II (lyoph.), 5 x 1 ml

These lyophilised Chromsystems controls are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures for the quantitative determination of antiepileptic drugs. While following the instructions the controls should be handled and measured in the same manner as research samples.

Technical Data

Concentrations

Please note: Concentration values shown here are typical. For lot specific concentration values please refer to the product insert supplied with the materials. The product inserts can also be requested from us directly or downloaded from our website after login.

Substance

Suggested value

Level I

Suggested range

Level I

Suggested value

Level II

Suggested range

Level II

10-OH-Carbamazepine

7.80

6.24-9.36

33.9

27.1-40.7

Carbamazepine

3.17

2.54-3.8

10.6

8.48-12.7

Carbamazepine-10.11-epoxide

1.14

0.912-1.37

7.68

6.14-9.22

Carbamazepine-Diol

0.978

0.782-1.17

8.34

6.67-10

Oxcarbazepine

0.402

0.322-0.482

2.81

2.25-3.37

Felbamate

25.1

20.1-30.1

89.3

71.4-107

Lacosamide

1.84

1.47-2.21

8.28

6.62-9.94

Lamotrigine

3.21

2.57-3.85

12.7

10.2-15.2

Levetiracetam

16.6

13.3-19.9

68.3

54.6-82

Rufinamide

7.83

6.26-9.4

25.8

20.6-31

Theophylline

9.38

7.5-11.3

18.8

15-22.6

Gabapentin

4.13

3.3-4.96

19.4

15.5-23.3

Pregabalin

1.15

0.92-1.38

8.91

7.13-10.7

Sultiame

1.71

1.37-2.05

11.1

8.88-13.3

Tiagabine (in µg/l)

34.9

27.9-41.9

170

136-204

Topiramate

3.04

2.43-3.65

21.4

17.1-25.7

Vigabatrin

5.35

4.28-6.42

30.7

24.6-36.8

N-Desmethylmesuximide

12.6

10.1-15.1

35.0

28-42

PEMA

2.09

1.67-2.51

8.28

6.62-9.94

Phenytoin

6.00

4.8-7.2

17.4

13.9-20.9

Primidone

5.19

4.15-6.23

14.1

11.3-16.9

Stiripentol

5.57

4.46-6.68

18.2

14.6-21.8

Ethosuximide

33.2

26.6-39.8

81.6

65.3-97.9

Phenobarbital

12.0

9.6-14.4

40.5

32.4-48.6

Valproic acid

43.3

34.6-52

87.7

70.2-105

Zonisamide

8.53

6.82-10.2

36.9

29.5-44.3

Brivaracetam

0.973

0.778-1.17

3.80

3.04-4.56

Perampanel (in µg/l)

175

140-210

1213

970-1456

Retigabine (in µg/l)

243

194-292

1786

1429-2143

Reconstitution

Carefully remove the metal seal and rubber stopper from the vials. (Caution when removing the metal seal: risk of injuries due to sharp cutting edges!). Add exactly 1.0 ml of distilled water into each vial. Return the stopper and incubate for 10 to 15 minutes at room temperature. Swirl the vials to dissolve the contents until homogeneity.

Storage conditions

Stored below -18 °C and unopened, the lyophilised controls are stable until the expiry date specified on the vial labels. The reconstituted controls can be stored in glass containers up to 2 days light protected and tightly capped at +2 to +8 C. If the controls cannot be used within this period, they should be aliquoted and stored frozen below -18 °C (up to 3 months). For more details about storage conditions please check your instruction manual.